SCHEMBL31663618

SCHEMBL31663618

N#Cc1c(-n2c3ccccc3c3ncccc32)cc(-n2c3ccccc3c3ncccc32)c(-n2c3ccccc3c3ncccc32)c1-c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 1/20 0.36
PDE9A O76083 3/20 0.35
PDE1C Q14123 2/20 0.35
HTR3A P46098 1/20 0.34
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
LMNA P02545 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
ADORA2A P29274 2/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
MAPK1 P28482 1/20 0.32
PLAUR Q03405 1/20 0.32
HSD17B10 Q99714 2/20 0.32
ADRA2A P08913 1/20 0.32
HTT P42858 1/20 0.32
ALOX15 P16050 1/20 0.32
PDE5A O76074 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31663571 0.84 KDM4E (0.39) CYP11B2ALDH1A1KDM4ELMNARXFP1
SCHEMBL24327957 0.83 CYP11B2 (0.39) CYP11B2PDE9APDE1CHTR3AALDH1A1
SCHEMBL24327954 0.83 CYP11B2 (0.39) CYP11B2PDE9APDE1CHTR3AALDH1A1
SCHEMBL31484547 0.82 MAPK14 (0.37) CYP11B2PDE9APDE1CHTR3AALDH1A1
SCHEMBL23342510 0.81 ABCG2 (0.38) CYP11B2ALDH1A1KDM4ELMNANPSR1
SCHEMBL17570601 0.80 CYP11B2 (0.40) CYP11B2PDE9AALDH1A1KDM4ELMNA
SCHEMBL31272927 0.80 SQOR (0.39) CYP11B2ALDH1A1KDM4ENPSR1RXFP1
SCHEMBL21840868 0.80 CYP11B2 (0.36) CYP11B2HTR3AALDH1A1KDM4ELMNA
SCHEMBL20595955 0.79 CYP11B2 (0.34) CYP11B2PDE9APDE1CHTR3AALDH1A1
SCHEMBL31273746 0.79 SQOR (0.37) CYP11B2ALDH1A1KDM4ENPSR1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 CYP11B2 1221/4885PDE9A 4069/4885PDE1C 4875/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 CYP11B2 1221/4885PDE9A 4069/4885PDE1C 4875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.